Skip to main content

Want a detailed portfolio tracker?

ORIC Pharmaceuticals (ORIC) P/E (2020 - 2026)

ORIC Pharmaceuticals (ORIC) P/E from Jun 30, 2020 to Jul 21, 2026. The TTM ORIC Pharmaceuticals (ORIC) P/E is -7.67. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ORIC Pharmaceuticals (ORIC)

YearP/EChange
2026-7.67+39.59%
2025-5.49+25.59%
2024-4.38-10.53%
2023-4.89+91.37%
2022-2.56-64.04%
2021-7.11-58.52%
2020-17.14N/A

Comparison ORIC Pharmaceuticals (ORIC) P/E with competitors

ORIC Pharmaceuticals (ORIC) P/E is -7.67.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-100.98%
FGENFibroGen Inc0.24-103.13%
CHRSCoherus Biosciences Inc0.85-111.06%
FBIOFortress Biotech Inc0.95-112.37%
ORMPOramed Pharmaceuticals Inc1.50-119.60%
AGENAgenus Inc3.01-139.24%
INVAInnoviva Inc3.15-141.12%
VXRTVaxart Inc3.55-146.28%
CRMDCorMedix Inc3.63-147.30%
CVACCureVac N.V.4.45-157.96%
GLPGGalapagos NV4.86-163.35%
SRPTSarepta Therapeutics Inc4.88-163.65%
ABEOAbeona Therapeutics Inc5.39-170.24%
ABUSArbutus Biopharma Corp5.60-172.95%
ZVRAZevra Therapeutics Inc5.89-176.75%
SPROSpero Therapeutics Inc6.23-181.20%
CGENCompugen Ltd6.31-182.32%
RIGLRigel Pharmaceuticals6.87-189.59%
SLXNSilexion Therapeutics Corp7.30-195.12%
OMEROmeros Corporation9.26-220.71%
AUPHAurinia Pharmaceuticals Inc9.58-224.96%
PLXProtalix BioTherapeutics Inc10.89-241.99%
ACADAcadia Pharmaceuticals Inc11.73-252.91%
TBPHTheravance Biopharma Inc12.26-259.86%
ADMAAdma Biologics Inc12.42-261.90%
HRMYHarmony Biosciences Holdings Inc13.82-280.18%
SABSSAB Biotherapeutics Inc14.14-284.30%
NAGENiagen Bioscience Inc14.82-293.19%
INCYIncyte Corp15.82-306.28%
REGNRegeneron Pharmaceuticals Inc15.86-306.73%
PBYIPuma Biotechnology Inc17.32-325.75%
CPRXCatalyst Pharmaceuticals Inc17.44-327.36%
EXELExelixis Inc17.54-328.65%
TGTXTG Therapeutics Inc18.97-347.26%
MDXGMimedx Group Inc20.55-367.95%
XOMAXOMA Royalty Corp22.87-398.23%
ARGXArgen X SE24.30-416.79%
CTMXCytomX Therapeutics Inc24.82-423.61%
XOMAOXOMA Royalty Corp25.34-430.43%
HALOHalozyme Therapeutics Inc25.62-434.07%
XOMAPXOMA Royalty Corp25.67-434.68%
VRTXVertex Pharmaceuticals Inc27.99-464.98%
RPRXRoyalty Pharma plc - Class A28.69-474.02%
SLNOSoleno Therapeutics Inc29.02-478.29%
ASNDAscendis Pharma A/S30.09-492.24%
LGNDLigand Pharmaceuticals Inc - Class B37.91-594.28%
APLSApellis Pharmaceuticals Inc39.02-608.74%
BMRNBiomarin Pharmaceutical Inc42.21-650.34%
KRYSKrystal Biotech Inc45.34-691.17%
ONCBeiGene Ltd69.54-1006.64%
PHARPharming Group N.V.75.03-1078.15%
TECHBio-Techne Corp101.96-1429.29%
VCELVericel Corp109.92-1533.11%
ALNYAlnylam Pharmaceuticals Inc117.96-1637.98%
GMABGenmab140.29-1929.05%
TLXTelix Pharmaceuticals Ltd162.15-2214.08%
CORTCorcept Therapeutics Inc212.86-2875.14%